These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18647600)

  • 1. A point mutation produced a class 3 aldehyde dehydrogenase with increased protective ability against the killing effect of cyclophosphamide.
    Ho KK; Mukhopadhyay A; Li YF; Mukhopadhyay S; Weiner H
    Biochem Pharmacol; 2008 Sep; 76(5):690-6. PubMed ID: 18647600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of aldophosphamide by human aldehyde dehydrogenase isozyme 3.
    Giorgianni F; Bridson PK; Sorrentino BP; Pohl J; Blakley RL
    Biochem Pharmacol; 2000 Aug; 60(3):325-38. PubMed ID: 10856427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection by transfected rat or human class 3 aldehyde dehydrogenase against the cytotoxic effects of oxazaphosphorine alkylating agents in hamster V79 cell lines. Demonstration of aldophosphamide metabolism by the human cytosolic class 3 isozyme.
    Bunting KD; Townsend AJ
    J Biol Chem; 1996 May; 271(20):11891-6. PubMed ID: 8662659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the mouse aldehyde dehydrogenases important in aldophosphamide detoxification.
    Manthey CL; Landkamer GJ; Sladek NE
    Cancer Res; 1990 Aug; 50(16):4991-5002. PubMed ID: 2379164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective assay of the cytosolic forms of the aldehyde dehydrogenase in rat, with possible significance for the investigations of cyclophosphamide cytotoxicity.
    Wierzchowski J; Wroczyński P; Interewicz E
    Acta Pol Pharm; 1996; 53(3):203-8. PubMed ID: 8960290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsic cellular resistance to oxazaphosphorines exhibited by a human colon carcinoma cell line expressing relatively large amounts of a class-3 aldehyde dehydrogenase.
    Rekha GK; Sreerama L; Sladek NE
    Biochem Pharmacol; 1994 Nov; 48(10):1943-52. PubMed ID: 7986206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human class 3 aldehyde dehydrogenase, and sensitization of tumor cells that express significant amounts of this enzyme to oxazaphosphorines, by the naturally occurring compound gossypol.
    Rekha GK; Sladek NE
    Adv Exp Med Biol; 1997; 414():133-46. PubMed ID: 9059615
    [No Abstract]   [Full Text] [Related]  

  • 8. De novo expression of transfected human class 1 aldehyde dehydrogenase (ALDH) causes resistance to oxazaphosphorine anti-cancer alkylating agents in hamster V79 cell lines. Elevated class 1 ALDH activity is closely correlated with reduction in DNA interstrand cross-linking and lethality.
    Bunting KD; Townsend AJ
    J Biol Chem; 1996 May; 271(20):11884-90. PubMed ID: 8662658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1 and tumor necrosis factor alpha induce class 1 aldehyde dehydrogenase mRNA and protein in bone marrow cells.
    Moreb JS; Turner C; Sreerama L; Zucali JR; Sladek NE; Schweder M
    Leuk Lymphoma; 1995 Dec; 20(1-2):77-84. PubMed ID: 8750626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced expressions of glucose-6-phosphate dehydrogenase and cytosolic aldehyde dehydrogenase and elevation of reduced glutathione level in cyclophosphamide-resistant human leukemia cells.
    Tsukamoto N; Chen J; Yoshida A
    Blood Cells Mol Dis; 1998 Jun; 24(2):231-8. PubMed ID: 9714700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detoxification of cyclophosphamide by human aldehyde dehydrogenase isozymes.
    von Eitzen U; Meier-Tackmann D; Agarwal DP; Goedde HW
    Cancer Lett; 1994 Jan; 76(1):45-9. PubMed ID: 8124665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of the cytotoxic action of mafosfamide by N-isopropyl-p-formylbenzamide, a metabolite of procarbazine.
    Maki PA; Sladek NE
    Cancer Res; 1991 Aug; 51(16):4170-5. PubMed ID: 1868438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of selective inhibitors for human aldehyde dehydrogenase 3A1 (ALDH3A1) for the enhancement of cyclophosphamide cytotoxicity.
    Parajuli B; Georgiadis TM; Fishel ML; Hurley TD
    Chembiochem; 2014 Mar; 15(5):701-12. PubMed ID: 24677340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of murine late spleen colony-forming cells (day-12 CFU-S) and hematopoietic repopulating cells to mafosfamide (ASTA Z 7557).
    Kohn FR; Sladek NE
    Biochem Pharmacol; 1987 Sep; 36(17):2805-11. PubMed ID: 2820422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of human multipotent and committed hematopoietic progenitor cells and malignant blood cells to oxazaphosphorines.
    Kohn FR; Landkamer GJ; Manthey CL; Ramsay NK; Sladek NE
    Cancer Res; 1987 Jun; 47(12):3180-5. PubMed ID: 3034402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldehyde dehydrogenase activity as the basis for the relative insensitivity of murine pluripotent hematopoietic stem cells to oxazaphosphorines.
    Kohn FR; Sladek NE
    Biochem Pharmacol; 1985 Oct; 34(19):3465-71. PubMed ID: 2996550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective protection by stably transfected human ALDH3A1 (but not human ALDH1A1) against toxicity of aliphatic aldehydes in V79 cells.
    Townsend AJ; Leone-Kabler S; Haynes RL; Wu Y; Szweda L; Bunting KD
    Chem Biol Interact; 2001 Jan; 130-132(1-3):261-73. PubMed ID: 11306050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xenobiotic oxidation catalyzed by aldehyde dehydrogenases.
    Sladek NE; Manthey CL; Maki PA; Zhang Z; Landkamer GJ
    Drug Metab Rev; 1989; 20(2-4):697-720. PubMed ID: 2680404
    [No Abstract]   [Full Text] [Related]  

  • 19. Sensitivity of aldehyde dehydrogenases in murine tumor and hematopoietic progenitor cells to inhibition by chloral hydrate as determined by the ability of chloral hydrate to potentiate the cytotoxic action of mafosfamide.
    Maki PA; Sladek NE
    Biochem Pharmacol; 1993 Jan; 45(1):231-9. PubMed ID: 8424816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldehyde dehydrogenase-mediated cellular relative insensitivity to the oxazaphosphorines.
    Sládek NE
    Curr Pharm Des; 1999 Aug; 5(8):607-25. PubMed ID: 10469894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.